recombinant humanized anti-CD25 monoclonal antibody

DRUG2 trials

Sponsors

Rongrong Liu, Beijing Children's Hospital

Conditions

EBV-T/NK LPDTransfusion Dependent Thalassemia

Phase 2

Evaluation of Recombinant Humanized Anti-CD25 Monoclonal Antibody for Preventing Graft-versus-host Disease After Haploidentical/matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Transfusion-dependent Thalassemia

RecruitingNCT06657391

Rongrong LiuTransfusion Dependent Thalassemia

Start: 2024-10-01End: 2027-09-30Target: 396Updated: 2024-10-28

Phase 4

Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Virus T/NK Lymphoproliferative Disease (EBV-T/NK LPD) and Prevention of Post Transplant Graft-versus-host Disease

RecruitingNCT07029958

Beijing Children's HospitalEBV-T/NK LPD

Start: 2024-11-12End: 2029-10-30Target: 48Updated: 2025-06-19